Showing results (11-20 of 118) with videos related to
Sort By:
Pageof 12
Neuropsychiatric Disease and Treatment|January 15, 2016
Use of antidepressants in the treatment of major depressive disorder in primary care during a period of economic crisisAntoni Sicras-Mainar, Ruth Navarro-ArtiedaDrug Design, Development and Therapy|June 28, 2014
Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderlyAntoni Sicras-Mainar, Ruth Navarro-ArtiedaThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 22, 2014
The influence of obesity and overweight on medical costs: a panel data perspectiveToni Mora, Joan Gil, Antoni Sicras-MainarThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 12, 2017
Uncontrolled diabetes and health care utilisation: panel data evidence from SpainJoan Gil, Antoni Sicras-Mainar, Eugenio ZucchelliTherapeutic Advances in Musculoskeletal Disease|May 17, 2021
Future projections of opioid use and cost in patients with chronic osteoarthritis pain in SpainJavier Rejas-Gutierrez, Antoni Sicras-Mainar, Josep DarbàGaceta Medica De Mexico|March 2, 2016
[Clinical characteristics and treatment response in adult patients with non-Hodgkin's chronic lymphocytic leukemia (CLL)]Antoni Sicras-Mainar, Antonio Castro, Ruth Navarro-ArtiedaRevista Peruana De Medicina Experimental Y Salud Publica|October 23, 2012
[Use of resources and costs associated to fractures in Spanish women]Antoni Sicras-Mainar, Ruth Navarro-Artieda, Jordi Ibáñez-NollaGastroenterologia Y Hepatologia|December 31, 2017
Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in SpainAntoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-ZafraRevista Espanola De Cardiologia (English Ed.)|January 3, 2015
Economic impact of heart failure according to the effects of kidney failureAntoni Sicras Mainar, Ruth Navarro Artieda, Jordi Ibáñez NollaClinicoeconomics and Outcomes Research : CEOR|June 18, 2015
Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in SpainAntoni Sicras-Mainar, Javier Rejas-Gutiérrez, Ruth Navarro-ArtiedaPageof 12